Related Experiment Videos
Experimental immunomodulation, sleep, and sleepiness in humans
T Pollmächer1, A Schuld, T Kraus
1Max Planck Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. topo@mpipsykl.mpg.de
Annals of the New York Academy of Sciences
|March 28, 2001
Summary
Experimental immunomodulation, like bacterial endotoxin administration, significantly impacts human sleep patterns. Inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-alpha), play a key role in mediating these sleep alterations during infection and inflammation.
Area of Science:
- Neuroscience
- Immunology
- Sleep Medicine
Background:
- Infections, inflammation, and autoimmune diseases disrupt well-being, cognition, and behavior.
- Host defense activation profoundly influences sleep-wake behavior.
Purpose of the Study:
- To review studies on experimental immunomodulation's effects on human sleep and sleepiness.
- To understand the role of inflammatory cytokines in sleep regulation.
Main Methods:
- Review of human studies involving experimental immunomodulation.
- Intravenous injection of bacterial endotoxin to model infection and cytokine release.
Main Results:
- Low-dose endotoxin, without fever, promotes non-rapid-eye-movement sleep.
- Febrile responses are associated with significant sleep disturbances.
- Tumor necrosis factor-alpha (TNF-alpha) is identified as a key mediator.
Conclusions:
- Human sleep is highly sensitive to host defense activation.
- Inflammatory cytokines, like TNF-alpha, mediate sleep changes during infection.
- Cytokines may also be involved in normal sleep regulation and sedative drug effects.